Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://cheloniophilie.com
Are you over 18 and want to see adult content?
A complete backup of https://leidos.com
Are you over 18 and want to see adult content?
A complete backup of https://elanaspantry.com
Are you over 18 and want to see adult content?
A complete backup of https://vectonemobile.co.uk
Are you over 18 and want to see adult content?
A complete backup of https://persianpet.org
Are you over 18 and want to see adult content?
A complete backup of https://gezigeek.com
Are you over 18 and want to see adult content?
A complete backup of https://mccannworldgroup.com
Are you over 18 and want to see adult content?
A complete backup of https://impressionen.de
Are you over 18 and want to see adult content?
A complete backup of https://sideline.com
Are you over 18 and want to see adult content?
A complete backup of https://technologyrater.com
Are you over 18 and want to see adult content?
A complete backup of https://subtesty.pl
Are you over 18 and want to see adult content?
A complete backup of https://lectura.de
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of www.model-kartei.de
Are you over 18 and want to see adult content?
A complete backup of dirtyhomeclips.com
Are you over 18 and want to see adult content?
A complete backup of sonovinhasbr.com
Are you over 18 and want to see adult content?
A complete backup of webcamsdolls.com
Are you over 18 and want to see adult content?
A complete backup of www.www.petticoated.com
Are you over 18 and want to see adult content?
A complete backup of www.www.millionairematch.com
Are you over 18 and want to see adult content?
A complete backup of fluffychicks.net
Are you over 18 and want to see adult content?
A complete backup of www.tastyblacks.com
Are you over 18 and want to see adult content?
A complete backup of www.www.enature.tv
Are you over 18 and want to see adult content?
Text
of the
CURRENT ISSUE TABLE OF CONTENTS: LUNG CANCER Microsimulation modeling of extended annual CT screening among lung cancer cases in the National Lung Screening Trial. Anton Schreuder, Onno M. Mets, Cornelia M. Schaefer-Prokop, Colin Jacobs, Mathias Prokop. Published online: April 07, 2021. LIST OF ISSUES: LUNG CANCER 2021 ( Volume 157) July 2021, In Progress. An issue that is "In Progress" contains final, fully citable articles that are published online but the issue is awaiting more articles before it can be considered "final." Individual article details such as volume, issue and page numbers will not change. ARTICLES IN PRESS: LUNG CANCER Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada. Didier Debieuvre, Rosalyn A. Juergens, Bernard Asselain, Daniela Waldenberger, Victoria Allan, Martin Sebastian. Published online: April 30, 2021. AIMS AND SCOPE: LUNG CANCER Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment TABLE OF CONTENTS PAGE: LUNG CANCER Psychosocial consequences of a three-month follow-up after receiving an abnormal lung cancer CT-screening result: A longitudinal survey. Christina Sadolin Damhus, Julie Greve Quentin, Jessica Malmqvist, Volkert Siersma, John Brodersen. Published online: March 09, 2021. TABLE OF CONTENTS PAGE: LUNG CANCER Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050) Ying Cheng, Tony S. Mok, Xiangdong Zhou, Fanfan Zhu, Keith D. Wilner, Yi-Long Wu. Published online: February 23, 2021. TABLE OF CONTENTS PAGE: LUNG CANCER Table of Contents page: Lung Cancer. Volume 127 Supplement 1 S1-S103. Poster abstracts of the 17th Annual British Thoracic Oncology Group Conference 2019. 23 January 2019 - 25 January 2019. Current Issue. TABLE OF CONTENTS PAGE: LUNG CANCER Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study. Salomon Tendler, Marit Holmqvist, Gunnar Wagenius, Rolf Lewensohn, Mats Lambe, Luigi De Petris. Published online: November 14, 2019. TABLE OF CONTENTS PAGE: LUNG CANCER Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy — A retrospective study HOME PAGE: LUNG CANCERHOMESUBSCRIBEARTICLES IN PRESSCURRENT ISSUELIST OF ISSUESPERMISSIONS About BTOG. The International Lung Cancer Consortium (ILCCO) is an international group of lung cancer researchers, established in 2004 with the aim of sharing comparable data from ongoing lung cancer case-control and cohort studies. Questionnaire data from a total of 26000 case-control pairs, and the biological samples from the majorityof the
CURRENT ISSUE TABLE OF CONTENTS: LUNG CANCER Microsimulation modeling of extended annual CT screening among lung cancer cases in the National Lung Screening Trial. Anton Schreuder, Onno M. Mets, Cornelia M. Schaefer-Prokop, Colin Jacobs, Mathias Prokop. Published online: April 07, 2021. LIST OF ISSUES: LUNG CANCER 2021 ( Volume 157) July 2021, In Progress. An issue that is "In Progress" contains final, fully citable articles that are published online but the issue is awaiting more articles before it can be considered "final." Individual article details such as volume, issue and page numbers will not change. ARTICLES IN PRESS: LUNG CANCER Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada. Didier Debieuvre, Rosalyn A. Juergens, Bernard Asselain, Daniela Waldenberger, Victoria Allan, Martin Sebastian. Published online: April 30, 2021. AIMS AND SCOPE: LUNG CANCER Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment TABLE OF CONTENTS PAGE: LUNG CANCER Psychosocial consequences of a three-month follow-up after receiving an abnormal lung cancer CT-screening result: A longitudinal survey. Christina Sadolin Damhus, Julie Greve Quentin, Jessica Malmqvist, Volkert Siersma, John Brodersen. Published online: March 09, 2021. TABLE OF CONTENTS PAGE: LUNG CANCER Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050) Ying Cheng, Tony S. Mok, Xiangdong Zhou, Fanfan Zhu, Keith D. Wilner, Yi-Long Wu. Published online: February 23, 2021. TABLE OF CONTENTS PAGE: LUNG CANCER Table of Contents page: Lung Cancer. Volume 127 Supplement 1 S1-S103. Poster abstracts of the 17th Annual British Thoracic Oncology Group Conference 2019. 23 January 2019 - 25 January 2019. Current Issue. TABLE OF CONTENTS PAGE: LUNG CANCER Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study. Salomon Tendler, Marit Holmqvist, Gunnar Wagenius, Rolf Lewensohn, Mats Lambe, Luigi De Petris. Published online: November 14, 2019. TABLE OF CONTENTS PAGE: LUNG CANCER Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy — A retrospective study TABLE OF CONTENTS PAGE: LUNG CANCER Evaluation of variant frequency in SARS-CoV-2 infection-related genes utilizing lung cancer genomic database. Yuji Shibata, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto. Published online: December 18,2020. p199-201.
TABLE OF CONTENTS PAGE: LUNG CANCER Factors associated with treatment receipt and overall survival for patients with locally advanced large cell neuroendocrine carcinoma of the lung: A National Cancer Database analysis. Vladimir Limonnik, Stephen Abel, Gene G. Finley, Gregory S. Long, Rodney E. TABLE OF CONTENTS PAGE: LUNG CANCER Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study. Salomon Tendler, Marit Holmqvist, Gunnar Wagenius, Rolf Lewensohn, Mats Lambe, Luigi De Petris. Published online: November 14, 2019. TABLE OF CONTENTS PAGE: LUNG CANCER Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902) Shotaro Ito, HajimeAsahina,
TABLE OF CONTENTS PAGE: LUNG CANCER Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases. Jing Zhao, Chao Guo, Zhiming Ma, Hongsheng Liu, Chuhu Yang, TABLE OF CONTENTS PAGE: LUNG CANCER Corrigendum to ‘Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand’ [Lung Cancervolume (124) 233
TABLE OF CONTENTS PAGE: LUNG CANCER Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer. Eva Boysen Fynboe Ebert, Tine McCulloch, Karin Holmskov Hansen, Hanne Linnet, Boe Sorensen, Peter Meldgaard. Published online: December 30, 2019.CONTACT INFORMATION
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password TABLE OF CONTENTS PAGE: LUNG CANCER Intestinal bleeding in disseminated non-small cell lung cancer. Carlos Centeno Cortés, Marı́a José Borau Clavero, Alvaro Sanz Rubiales, Francisco López-Lara Martı́n TABLE OF CONTENTS PAGE: LUNG CANCER Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line – Results from the prospective German TLK cohort study. Claus-Christoph Steffens, Corinna Elender, Ulrich Hutzschenreuter, Martina Jänicke, Norbert Marschner. HOME PAGE: LUNG CANCERHOMESUBSCRIBEARTICLES IN PRESSCURRENT ISSUELIST OF ISSUESPERMISSIONS About BTOG. The International Lung Cancer Consortium (ILCCO) is an international group of lung cancer researchers, established in 2004 with the aim of sharing comparable data from ongoing lung cancer case-control and cohort studies. Questionnaire data from a total of 26000 case-control pairs, and the biological samples from the majorityof the
CURRENT ISSUE TABLE OF CONTENTS: LUNG CANCER Microsimulation modeling of extended annual CT screening among lung cancer cases in the National Lung Screening Trial. Anton Schreuder, Onno M. Mets, Cornelia M. Schaefer-Prokop, Colin Jacobs, Mathias Prokop. Published online: April 07, 2021. LIST OF ISSUES: LUNG CANCER 2021 ( Volume 157) July 2021, In Progress. An issue that is "In Progress" contains final, fully citable articles that are published online but the issue is awaiting more articles before it can be considered "final." Individual article details such as volume, issue and page numbers will not change. ARTICLES IN PRESS: LUNG CANCER Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada. Didier Debieuvre, Rosalyn A. Juergens, Bernard Asselain, Daniela Waldenberger, Victoria Allan, Martin Sebastian. Published online: April 30, 2021. TABLE OF CONTENTS PAGE: LUNG CANCER CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer. Moushumi Suryavanshi, Jiten Jaipuria, Manoj Kumar Panigrahi, Ullas Batra, D.C. Doval, Vineet Talwar. Published online: August 05, 2020. TABLE OF CONTENTS PAGE: LUNG CANCER Table of Contents page: Lung Cancer. Volume 127 Supplement 1 S1-S103. Poster abstracts of the 17th Annual British Thoracic Oncology Group Conference 2019. 23 January 2019 - 25 January 2019. Current Issue. WWW.LUNGCANCERJOURNAL.INFOWEB VIEW Figure A1. Cumulative incidence of thromboembolic events by Kaplan-Meier failure estmiate. Time zero is day of lung cancer diagnosis and dashed reference lines depict +/-90 day interval fromdiagnosis.
HOME PAGE: LUNG CANCER Home Page: Lung Cancer SITUATION DATE OF PROGRESSION OR CENSOR CENSORED OR HAZARD 0.84 (0.60-1.19) SA2 New anticancer treatment (systemic therapy) started before progression per RECIST v.1.1 as specified in (A) or death Date of start of new anticancer treatment Censored 0.80(0.56-1.13)
WWW.LUNGCANCERJOURNAL.INFOWEB VIEW Patient and disease characteristics in REVEL patients with a best response of complete response, partial response, or stable disease tofirst-line therapy.
HOME PAGE: LUNG CANCERHOMESUBSCRIBEARTICLES IN PRESSCURRENT ISSUELIST OF ISSUESPERMISSIONS About BTOG. The International Lung Cancer Consortium (ILCCO) is an international group of lung cancer researchers, established in 2004 with the aim of sharing comparable data from ongoing lung cancer case-control and cohort studies. Questionnaire data from a total of 26000 case-control pairs, and the biological samples from the majorityof the
CURRENT ISSUE TABLE OF CONTENTS: LUNG CANCER Microsimulation modeling of extended annual CT screening among lung cancer cases in the National Lung Screening Trial. Anton Schreuder, Onno M. Mets, Cornelia M. Schaefer-Prokop, Colin Jacobs, Mathias Prokop. Published online: April 07, 2021. LIST OF ISSUES: LUNG CANCER 2021 ( Volume 157) July 2021, In Progress. An issue that is "In Progress" contains final, fully citable articles that are published online but the issue is awaiting more articles before it can be considered "final." Individual article details such as volume, issue and page numbers will not change. ARTICLES IN PRESS: LUNG CANCER Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada. Didier Debieuvre, Rosalyn A. Juergens, Bernard Asselain, Daniela Waldenberger, Victoria Allan, Martin Sebastian. Published online: April 30, 2021. TABLE OF CONTENTS PAGE: LUNG CANCER CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer. Moushumi Suryavanshi, Jiten Jaipuria, Manoj Kumar Panigrahi, Ullas Batra, D.C. Doval, Vineet Talwar. Published online: August 05, 2020. TABLE OF CONTENTS PAGE: LUNG CANCER Table of Contents page: Lung Cancer. Volume 127 Supplement 1 S1-S103. Poster abstracts of the 17th Annual British Thoracic Oncology Group Conference 2019. 23 January 2019 - 25 January 2019. Current Issue. WWW.LUNGCANCERJOURNAL.INFOWEB VIEW Figure A1. Cumulative incidence of thromboembolic events by Kaplan-Meier failure estmiate. Time zero is day of lung cancer diagnosis and dashed reference lines depict +/-90 day interval fromdiagnosis.
HOME PAGE: LUNG CANCER Home Page: Lung Cancer SITUATION DATE OF PROGRESSION OR CENSOR CENSORED OR HAZARD 0.84 (0.60-1.19) SA2 New anticancer treatment (systemic therapy) started before progression per RECIST v.1.1 as specified in (A) or death Date of start of new anticancer treatment Censored 0.80(0.56-1.13)
WWW.LUNGCANCERJOURNAL.INFOWEB VIEW Patient and disease characteristics in REVEL patients with a best response of complete response, partial response, or stable disease tofirst-line therapy.
TABLE OF CONTENTS PAGE: LUNG CANCER Table of Contents page: Lung Cancer. Volume 139 Supplement 1 S1-S96. Poster abstracts of the 18th Annual British Thoracic Oncology Group Conference 2020. 29 January 2020 - TABLE OF CONTENTS PAGE: LUNG CANCER Factors associated with treatment receipt and overall survival for patients with locally advanced large cell neuroendocrine carcinoma of the lung: A National Cancer Database analysis. Vladimir Limonnik, Stephen Abel, Gene G. Finley, Gregory S. Long, Rodney E. TABLE OF CONTENTS PAGE: LUNG CANCER CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer. Moushumi Suryavanshi, Jiten Jaipuria, Manoj Kumar Panigrahi, Ullas Batra, D.C. Doval, Vineet Talwar. Published online: August 05, 2020. TABLE OF CONTENTS PAGE: LUNG CANCER Cell-free Chromatin Immunoprecipitation (cfChIP) from blood plasma can determine gene-expression in tumors from non-small-cell lung cancer patients. Johan Vad-Nielsen, Peter Meldgaard, Boe Sandahl Sorensen, Anders Lade Nielsen. Published online: July 23, 2020. TABLE OF CONTENTS PAGE: LUNG CANCER Psychosocial consequences of a three-month follow-up after receiving an abnormal lung cancer CT-screening result: A longitudinal survey. Christina Sadolin Damhus, Julie Greve Quentin, Jessica Malmqvist, Volkert Siersma, John Brodersen. Published online: March 09, 2021. TABLE OF CONTENTS PAGE: LUNG CANCER Cost-effectiveness evaluation of robotic-assisted thoracoscopic surgery versus open thoracotomy and video-assisted thoracoscopic surgery for operable non-small cell lung cancer. Dali Chen, Poming Kang, Shaolin Tao, Qingyuan Li, Ruwen Wang, Qunyou Tan. Published online: January 10, 2021. TABLE OF CONTENTS PAGE: LUNG CANCER Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer. Eva Boysen Fynboe Ebert, Tine McCulloch, Karin Holmskov Hansen, Hanne Linnet, Boe Sorensen, Peter Meldgaard. Published online: December 30, 2019. TABLE OF CONTENTS PAGE: LUNG CANCER Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study. Salomon Tendler, Marit Holmqvist, Gunnar Wagenius, Rolf Lewensohn, Mats Lambe, Luigi De Petris. Published online: November 14, 2019. TABLE OF CONTENTS PAGE: LUNG CANCER Increased incidence, morbidity and mortality rates for lung cancer in women in Brazil between 2000 and 2014: An analysis of three types of sources of secondary data. Guilherme Jorge Costa, Maria Júlia Gonçalves de Mello, Carlos Gil Ferreira, Anke Bergmann, Luiz Claudio Santos Thuler. Published online: September 11, 2018. EDITORIAL BOARD: LUNG CANCER Editorial Board Editor-in-Chief. Rolf Stahel, MD, Zurich, Switzerland; Deputy Editors. Paul Baas, Amsterdam, Netherlands; Martin Edelman, Philadelphia, United States HOME PAGE: LUNG CANCERHOMESUBSCRIBEARTICLES IN PRESSCURRENT ISSUELIST OF ISSUESPERMISSIONS x Thymoma associated pure red cell aplasia (PRCA) is a rare disorder linked to thymoma that could be an autoimmune phenomenon, as myasthenia . Some etiologies are proposed: role of self-reactive T-cells, clonal lymphocyte disorder and anti-erythroblast antibodies . Classical symptoms of anemia such as fatigue, weakness, pallor or dyspnea may reveal PRCA. CURRENT ISSUE TABLE OF CONTENTS: LUNG CANCER Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902) Shotaro Ito, HajimeAsahina,
LIST OF ISSUES: LUNG CANCER An issue that is "In Progress" contains final, fully citable articles that are published online but the issue is awaiting more articles before it can be considered "final." ARTICLES IN PRESS: LUNG CANCER The modification of T description according to visceral pleural invasion and tumor size from 3.1 cm to 4.0 cm in Non-Small Cell Lung Cancer: a retrospective analysis based on the SEER database TABLE OF CONTENTS PAGE: LUNG CANCER Time from 2-week wait (2WW) referrals to giving patient’s a diagnosis of no cancer or cancer: is the faster diagnostic standard for patients referred on the lung cancer pathway met in our districtgeneral hospital?
TABLE OF CONTENTS PAGE: LUNG CANCER Poster abstracts of the 17th Annual British Thoracic Oncology GroupConference 2019
CONTACT INFORMATION
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password TABLE OF CONTENTS PAGE: LUNG CANCER Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer TABLE OF CONTENTS PAGE: LUNG CANCER Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy — A retrospective study TABLE OF CONTENTS PAGE: LUNG CANCER Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer HOME PAGE: LUNG CANCERHOMESUBSCRIBEARTICLES IN PRESSCURRENT ISSUELIST OF ISSUESPERMISSIONS x Thymoma associated pure red cell aplasia (PRCA) is a rare disorder linked to thymoma that could be an autoimmune phenomenon, as myasthenia . Some etiologies are proposed: role of self-reactive T-cells, clonal lymphocyte disorder and anti-erythroblast antibodies . Classical symptoms of anemia such as fatigue, weakness, pallor or dyspnea may reveal PRCA. CURRENT ISSUE TABLE OF CONTENTS: LUNG CANCER Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902) Shotaro Ito, HajimeAsahina,
LIST OF ISSUES: LUNG CANCER An issue that is "In Progress" contains final, fully citable articles that are published online but the issue is awaiting more articles before it can be considered "final." ARTICLES IN PRESS: LUNG CANCER The modification of T description according to visceral pleural invasion and tumor size from 3.1 cm to 4.0 cm in Non-Small Cell Lung Cancer: a retrospective analysis based on the SEER database TABLE OF CONTENTS PAGE: LUNG CANCER Time from 2-week wait (2WW) referrals to giving patient’s a diagnosis of no cancer or cancer: is the faster diagnostic standard for patients referred on the lung cancer pathway met in our districtgeneral hospital?
TABLE OF CONTENTS PAGE: LUNG CANCER Poster abstracts of the 17th Annual British Thoracic Oncology GroupConference 2019
CONTACT INFORMATION
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password TABLE OF CONTENTS PAGE: LUNG CANCER Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer TABLE OF CONTENTS PAGE: LUNG CANCER Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy — A retrospective study TABLE OF CONTENTS PAGE: LUNG CANCER Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer TABLE OF CONTENTS PAGE: LUNG CANCER Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer. Sanjay Popat, Odd Terje Brustugun, TABLE OF CONTENTS PAGE: LUNG CANCER Time from 2-week wait (2WW) referrals to giving patient’s a diagnosis of no cancer or cancer: is the faster diagnostic standard for patients referred on the lung cancer pathway met in our districtgeneral hospital?
CONTACT INFORMATION
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password TABLE OF CONTENTS PAGE: LUNG CANCER PL-4 Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT induction followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): First outcome analysis of North American Intergroup trial 0139 (RTOG93-09)
TABLE OF CONTENTS PAGE: LUNG CANCER Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenterretrospective study
TABLE OF CONTENTS PAGE: LUNG CANCER Impact of serum vascular endothelial growth factor and interleukin-6 on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancer TABLE OF CONTENTS PAGE: LUNG CANCER Synergizing systemic responses by combining immunotherapy with radiotherapy in metastatic non-small cell lung cancer: The potential of the abscopal effect TABLE OF CONTENTS PAGE: LUNG CANCER Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer TABLE OF CONTENTS PAGE: LUNG CANCER A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer. Hua Cheng, Xiao-Jian Li, Xiao-Jin Wang,Hong-Cheng Zhong,
HOME PAGE: LUNG CANCER Home Page: Lung Cancer Skip to Main Content__
LOGIN TO YOUR ACCOUNTEmail/Username
PasswordShow
Forgot password?
Remember me
Don’t have an account?Create a Free Account__
If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting yourpassword
Email*
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your passwordCancel
___Close_
* Home
* Articles and Issues__* __Back
* Articles in Press
* Current Issue
* List of Issues
* For Authors__
* __Back
* About Open Access __ * Author Information* Permissions
* Researcher Academy __ * Submit a Manuscript __* Journal Info__
* __Back
* About Open Access __* About the Journal
* Abstracting/Indexing * Advertising Information __ * Career Opportunities __ * Contact Information* Editorial Board
* Pricing
* New Content Alerts* Subscribe
* Society Info__
* __Back
* International Lung Cancer Consortium (ILCCO) __ * European Thoracic Oncology Platform (ETOP) __ * British Thoracic Oncology Group (BTOG) __ * More Periodicals__* __Back
* Find a Periodical
* Go to Product Catalog __ * Oncology Advance __* Register
* Subscribe
* Claim
__
Go search
All ContentArticle TitleAuthorsKeywordsAbstractArticle Title,Abstract, Keywords
Advanced Search
Save
search
Please enter a term before submitting your search.Ok__
* Log in
* Register
*
Log in
* Subscribe
* Claim
ISSUE HIGHLIGHTS
Reviews
*
CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical trials Navin K. Chintala, David Restle, Hue Quach, Jasmeen Saini, Rebecca Bellis, Michael Offin, Jason Beattie, Prasad S. Adusumilli DOI: https://doi.org/10.1016/j.lungcan.2021.05.004 Lung Cancer, Vol. 157 PreviewFull-Text HTML*
Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era Francesco Passiglia, Gianmarco Leone, Emanuela Olmetto, Marco Donatello Delcuratolo, Fabrizio Tabbò, Maria Lucia Reale, Valentina Bertaglia, Lorena Consito, Paolo Bironzo, Enrica Capelletto, SilviaNovello
DOI: https://doi.org/10.1016/j.lungcan.2021.05.009 Lung Cancer, Vol. 157 PreviewFull-Text HTML*
Management of thymoma associated autoimmune pure red cell aplasia: Case report and systematic review of the literature Bastien Lesire, Valérie Durieux, Bogdan Grigoriu, Nicolas Girard,Thierry Berghmans
DOI: https://doi.org/10.1016/j.lungcan.2021.05.010 Lung Cancer, Vol. 157 PreviewFull-Text HTMLanemia.
*
ARTICLES IN PRESS
*
Most Read
*
Most Cited
*
Effectiveness and safety of immunotherapy in NSCLC patients with ECOG PS score ≥2 – systematic review and meta-analysis Bartłomiej Tomasik, Michał Bieńkowski, Marcin Braun, Sanjay Popat,Rafał Dziadziuszko
DOI: https://doi.org/10.1016/j.lungcan.2021.06.004 Publication stage: In Press Journal Pre-Proof Published online: June 5, 2021Full-Text HTML
Supplemental
Materials
*
Importance of designing sample size, subgroup analysis, and covariate presentation: towards a better randomized controlled trial Akio Hara, Takashi Yoshioka DOI: https://doi.org/10.1016/j.lungcan.2021.06.007 Publication stage: In Press Journal Pre-Proof Published online: June 4, 2021Full-Text HTML
*
DNA and RNA sequencing revealed a complex intergenic-_ALK_ fusion in a lung adenocarcinoma patient who responded to TKI therapy Jiexia Zhang, Jian Huang, Qin Li, Huaming Lin, Zhiqiang Luo, RongrongChen
DOI: https://doi.org/10.1016/j.lungcan.2021.06.005 Publication stage: In Press Journal Pre-Proof Published online: June 4, 2021Full-Text HTML
*
The Rapidly Evolving Landscape of Novel Targeted Therapies in Advanced Non-Small Cell Lung Cancer Barbara Melosky, Paul Wheatley-Price, Rosalyn A. Juergens, Adrian Sacher, Natasha B. Leighl, Ming-Sound Tsao, Parneet Cheema, Stephanie Snow, Geoffrey Liu, Paul B. Card, Quincy Chu DOI: https://doi.org/10.1016/j.lungcan.2021.06.002 Publication stage: In Press Journal Pre-Proof Published online: June 4, 2021Full-Text HTML
Supplemental
Materials
*
The modification of T description according to visceral pleural invasion and tumor size from 3.1 cm to 4.0 cm in Non-Small Cell Lung Cancer: a retrospective analysis based on the SEER database Mengfan Qi, Dongliang Bian, Jing Zhang, Xinsheng Zhu, Caicun Zhou, LeiZhang
DOI: https://doi.org/10.1016/j.lungcan.2021.06.003 Publication stage: In Press Journal Pre-Proof Published online: June 4, 2021Full-Text HTML
*
Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada DOI: https://doi.org/10.1016/j.lungcan.2021.04.022 Lung Cancer, Vol. 157Open Access*
Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis DOI: https://doi.org/10.1016/j.lungcan.2021.05.002 Lung Cancer, Vol. 157Open Access*
Thromboembolism in _ALK_+ and _ROS1_+ NSCLC patients: A systematic review and meta-analysis DOI: https://doi.org/10.1016/j.lungcan.2021.05.019 Lung Cancer, Vol. 157Open Access*
The evolving landscape of biomarker testing for non-small cell lungcancer in Europe
DOI: https://doi.org/10.1016/j.lungcan.2021.02.026 Lung Cancer, Vol. 154Open Access*
Real-world outcomes of immunotherapy–based regimens in first-line advanced non-small cell lung cancer DOI: https://doi.org/10.1016/j.lungcan.2021.04.007 Lung Cancer, Vol. 156Open Access2020 CITED ARTICLES
ISSN%280169-5002%29+AND+PUBYEAR+IS+2020+ ------------------------- * Covid-19 and lung cancer: A greater fatality rate? * Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national database analysis
* Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small celllung cancer
* The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer * Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy*
ABOUT ILCCO
*
About ETOP
*
About BTOG
The International Lung Cancer Consortium (ILCCO) is an international group of lung cancer researchers, established in 2004 with the aim of sharing comparable data from ongoing lung cancer case-control and cohort studies. Questionnaire data from a total of 26000 case-control pairs, and the biological samples from the majority of the subjects would be available. These studies are from different geographical areas and ethnicities. The overall objectives are to achieve greater power, especially for subgroup analyses, reduce duplication of research effort, replicate novel findings, and afford substantial cost savings through large collaborative efforts. European Thoracic Oncology Platform ETOP comprises 30 of the leading European Thoracic Oncology clinical and translational research groups and associations. The European Thoracic Oncology Platform (ETOP) is a foundation with the purpose to promote exchange and research in the field of thoracic malignancies in Europe. It is a non-profit organisation with its legal seat in Bern, Switzerland. The specific aims of ETOP are as follows: * To serve as a meeting platform for European study groups and institutions dealing with thoracic malignancies * To foster intergroup studies among, but not exclusively, European study groups and institutions * To sponsor and/or perform own studies * To foster scientific exchange on laboratory and clinical issues among interested parties and beyond * To provide knowledge to partners in the field British Thoracic Oncology Group (BTOG) was established in 2002 and aims to improve the care of patients with thoracic malignancies through multidisciplinary education, developing and advising on guidelines for patient care and to facilitate and nurture clinical trial ideas into full protocols. BTOG represents all the disciplines involved in the care of lung cancer and mesothelioma throughout the UK. All individuals involved in any aspect of lung cancer or mesothelioma research, care or treatment are eligible to become members of BTOG. BTOG's annual conference is held in Januaryevery year.
SOCIAL MEDIA
CURRENT ISSUE
* July 2021
* Volume 157
Subscribe to JournalJuly 2021
Volume 157
Submit Paper
Access this journal on ScienceDirect Visit ScienceDirect to see if you have access via your institution.* Mendeley
AddThis
LIST OF ISSUES
Supports Open Access Learn more about open access options.
Past Issues
Receive New Content AlertsFree Trial Issue
JOURNAL METRICS
2019 Impact Factor: 4.702 View More on Journal Insights 2019 Journal Citation Report Clarivate Analytics, 2020ABOUT _LUNG CANCER_
Original research articles, early reports, review articles, commentaries and editorials covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are all welcome. Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review. Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers. Manuscripts should be submitted online at https://www.editorialmanager.com/LUNGCANCER and the instructions on this site should be closely followed.JOURNAL INSIGHTS
These journal metricsprovide
authors with extra insight into the journals and help them in their journal selection process when submitting an article for publication.JOURNAL ACCESS
Articles are available from 1985 to the present. Access to abstracts is complimentary. Access to full text is limited to print subscribers. Register or login to: Buy a Subscription Now Activate Online Access PUBLISHING INFORMATION _Lung Cancer_ is published by Elsevier for the International Lung Cancer Consortium (ILCCO) , European Thoracic Oncology Platform (ETOP) , and the British Thoracic Oncology Group (BTOG).
New Job Listings
Job listings provided by myhealthtalent.comONCOLOGY
* Gynecologic Oncologist Memorial Healthcare System · Fort Lauderdale, Florida * Gynecologic Oncology - Community Private Practice Memorial Healthcare System · Broward County, Florida * Gynecologic Pathologist University of Pennsylvania · Philadelphia, Pennsylvania * Advanced Practice Registered Nurse - Thoracic Head & Neck MedicalOncology
MD Anderson Cancer Center · Old Sixth Ward, TX * Physician, Medical Oncology - 50K Sign On Bonus for External Candidates Only - Las Vegas, NV UnitedHealth Group · Garth, TX* Home
* Articles and Issues* Articles in Press
* Current Issue
* List of Issues
* For Authors
* About Open Access
* Author Information* Permissions
* Researcher Academy * Submit a Manuscript* Journal Info
* About Open Access
* About the Journal
* Abstracting/Indexing * Advertising Information * Career Opportunities * Contact Information* Editorial Board
* Pricing
* New Content Alerts* Subscribe
* Society Info
* International Lung Cancer Consortium (ILCCO) * European Thoracic Oncology Platform (ETOP) * British Thoracic Oncology Group (BTOG)* More Periodicals
* Find a Periodical
* Go to Product Catalog* Oncology Advance
We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Settings for this site. Copyright © 2021 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcareprofessionals.
* Privacy Policy
* Terms and Conditions* Accessibility
* Help & Contact
Click to get updates and verify authenticity. Submit your next paper to Lung Cancer We use cookies to analyse and improve our service, to improve and personalise content, advertising and your digital experience. We also share information about your use of our site with our social media, advertising and analytics partners. Cookie Policy Cookie Settings Accept all cookiesDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0